International Journal of Endocrinology
Volume 2014 (2014), Article ID 453781, 1 page
http://dx.doi.org/10.1155/2014/453781

Erratum

Erratum to “Growth Retardation in Children with Kidney Disease”

Paulina Salas,¹ Viola Pinto,¹ Josefina Rodriguez,² Maria Jose Zambrano,³ and Veronica Mericq⁴

¹Pediatric Nephrology Unit, Hospital Exequiel Gonzalez Cortes, 3301 Ramón Barros Luco, 8900000 Santiago, Chile
²Faculty of Medicine, University of Chile, 1027 Independencia Avenue, 8380000 Santiago, Chile
³Faculty of Medicine, Catholic University, 340 Libertador Bernardo O Higgins Avenue, 8320000 Santiago, Chile
⁴Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Casilla 226-3, 8320000 Santiago, Chile

Received 13 August 2014; Accepted 7 October 2014; Published 10 November 2014

Copyright © 2014 Paulina Salas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The abstract of the paper “Growth retardation in children with kidney disease” is corrected as follows. Chronic kidney disease (CKD) and end stage renal disease (ESRD) are usually associated with growth failure. The pathogenesis of growth delay in CKD is influenced by the degree of renal dysfunction and the presence of metabolic acidosis, protein calorie malnutrition, disorders of water and electrolyte metabolism, metabolic bone disease, anemia, and alterations in gonadotropic and somatothrophic axis but also comorbidities, factors associated with the treatment modality, and the genetic growth potential determined by midparental height. This review covers the current knowledge to optimize all aspects of treatment, including correction of metabolic disorders and appropriate use of hormone therapy.